CD8A and neoplasm: High-risk patients exhibited higher proportions of pro-tumor immune cells (M0 macrophages, M2 macrophages, and dendritic cells) and lower proportions of anti-tumor immune cells (M1 macrophages, CD4+ memory T cells, and CD8+ T cells) compared to low-risk patients (Fig. 6D).